These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7847445)

  • 1. The Semmes-Weinstein monofilament as a potential predictor of foot ulceration in patients with noninsulin-dependent diabetes.
    Olmos PR; Cataland S; O'Dorisio TM; Casey CA; Smead WL; Simon SR
    Am J Med Sci; 1995 Feb; 309(2):76-82. PubMed ID: 7847445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of neuropathy and high foot pressures in diabetic foot ulceration.
    Frykberg RG; Lavery LA; Pham H; Harvey C; Harkless L; Veves A
    Diabetes Care; 1998 Oct; 21(10):1714-9. PubMed ID: 9773736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpreting the results of the Semmes-Weinstein monofilament test: accounting for false-positive answers in the international consensus on the diabetic foot protocol by a new model.
    Slater RA; Koren S; Ramot Y; Buchs A; Rapoport MJ
    Diabetes Metab Res Rev; 2014 Jan; 30(1):77-80. PubMed ID: 23996640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensory thresholds of normal human feet.
    Jeng C; Michelson J; Mizel M
    Foot Ankle Int; 2000 Jun; 21(6):501-4. PubMed ID: 10884110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traditional Methods versus Quantitative Sensory Testing of the Feet at Risk: Results from the Rotterdam Diabetic Foot Study.
    Rinkel WD; Castro Cabezas M; Setyo JH; Van Neck JW; Coert JH
    Plast Reconstr Surg; 2017 Mar; 139(3):752e-763e. PubMed ID: 28234858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration.
    Armstrong DG; Lavery LA; Vela SA; Quebedeaux TL; Fleischli JG
    Arch Intern Med; 1998 Feb; 158(3):289-92. PubMed ID: 9472210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk assessment for foot ulcers among Tunisian subjects with diabetes: a cross sectional outpatient study.
    Zantour B; Bouchareb S; El Ati Z; Boubaker F; Alaya W; Kossomtini W; Sfar MH
    BMC Endocr Disord; 2020 Aug; 20(1):128. PubMed ID: 32831070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening patients at risk for diabetic foot ulceration: a comparison between measurement of vibration perception threshold and 10-g monofilament test.
    Richard JL; Reilhes L; Buvry S; Goletto M; Faillie JL
    Int Wound J; 2014 Apr; 11(2):147-51. PubMed ID: 22892021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes.
    Mayfield JA; Sugarman JR
    J Fam Pract; 2000 Nov; 49(11 Suppl):S17-29. PubMed ID: 11093555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which diabetic patients should receive podiatry care? An objective analysis.
    McGill M; Molyneaux L; Yue DK
    Intern Med J; 2005 Aug; 35(8):451-6. PubMed ID: 16176466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of factors associated with extremity ulceration in diabetic subjects with peripheral neuropathy].
    Porciúncula MV; Rolim LC; Garofolo L; Ferreira SR
    Arq Bras Endocrinol Metabol; 2007 Oct; 51(7):1134-42. PubMed ID: 18157390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening people with type 2 diabetes at risk for foot ulceration in Iran.
    Vatankhah N; Noudeh YJ; Khamseh ME; Baradaran HR
    Diabetes Technol Ther; 2010 Sep; 12(9):731-6. PubMed ID: 20707739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the Semmes-Weinstein monofilament in the strong heart study. Risk factors for clinical neuropathy.
    Sosenko JM; Sparling YH; Hu D; Welty T; Howard BV; Lee E; Robbins DC
    Diabetes Care; 1999 Oct; 22(10):1715-21. PubMed ID: 10526741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study on the significance of random intrasite placement of the Semmes-Weinstein monofilament.
    Slater RA; Koren S; Ramot Y; Buchs A; Rapoport MJ
    Diabetes Metab Res Rev; 2013 Mar; 29(3):235-8. PubMed ID: 23283830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of Vibratip in accurate identification of loss of protective sensation in the contralateral foot of patients admitted with a diabetic foot ulcer.
    Pasangha E; George B; Jayalakshmi V; Devi P; Ayyar V; Bantwal G
    Diabetes Metab Syndr; 2021; 15(3):857-862. PubMed ID: 33873055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial.
    Pham H; Armstrong DG; Harvey C; Harkless LB; Giurini JM; Veves A
    Diabetes Care; 2000 May; 23(5):606-11. PubMed ID: 10834417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of sensory neuropathy in diabetic patients without diabetic foot problems.
    Nather A; Neo SH; Chionh SB; Liew SC; Sim EY; Chew JL
    J Diabetes Complications; 2008; 22(2):126-31. PubMed ID: 18280443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Impact on prevalence of insensate foot and workload requirements.
    McGill M; Molyneaux L; Spencer R; Heng LF; Yue DK
    Diabetes Care; 1999 Apr; 22(4):598-602. PubMed ID: 10189538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the monofilament with other testing modalities for foot ulcer susceptibility.
    Miranda-Palma B; Sosenko JM; Bowker JH; Mizel MS; Boulton AJ
    Diabetes Res Clin Pract; 2005 Oct; 70(1):8-12. PubMed ID: 16126117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of neuropathic foot ulceration in Sri Lankan diabetic patients.
    Fernando DJ
    Ceylon Med J; 1996 Sep; 41(3):96-8. PubMed ID: 8917968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.